Endogenous Insulin Production is Preserved in Type 1 Diabetes With Anti-TNF Drug

Updated June 24, 2020

Articles report on a study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration. The research found that golimumab, an anti-tumor-necrosis-factor drug, helped preserve the ability to make insulin (endogenous insulin) in newly diagnosed children and young adults with Type 1 diabetes.